Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Document Type
- Journal article (12)
Language
- English (12) (remove)
Keywords
- artificial intelligence (5)
- deep learning (3)
- machine learning (3)
- prediction (3)
- ARONJ (2)
- classification (2)
- head and neck cancer (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- COPD (1)
- HGF (1)
- HNSCC (1)
- L929 (1)
- LC/MS (1)
- MRONJ (1)
- Met (1)
- OHIP-49 (1)
- ONJ (1)
- PD-L1 (1)
- SWLS (1)
- X-ray (1)
- agar diffusion test (1)
- alveolar bone loss (1)
- amino acid (1)
- ampicillin (1)
- antibiotic bone concentration (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- beta-lactam (1)
- bone loss (1)
- caloric restriction (1)
- cancer (1)
- complications (1)
- computer-aided (1)
- design (1)
- donor-site morbidity (1)
- fibula (1)
- free skin grafts (1)
- gingivitis (1)
- graft (1)
- immune therapy (1)
- ischemia (1)
- jaw bone (1)
- length of stay (1)
- liquid chromatography/mass spectrometry (1)
- mandibular (1)
- manufacturing (CAD/CAM) (1)
- mass spectrometry (1)
- maxillofacial surgery (1)
- medication-related osteonecrosis of the jaw (1)
- metabolism (1)
- methionine restriction (1)
- model (1)
- object detection (1)
- operative planning (1)
- oral health (1)
- oral microbiome (1)
- oral-health-related quality of life (1)
- oro-antral communication (1)
- oro-antral fistula (1)
- oroantral fistula (1)
- osteocutaneous (1)
- periodontitis (1)
- planning (1)
- platelet-rich fibrin (1)
- preoperative (1)
- radial forearm flap (1)
- radiographic bone loss (1)
- reconstruction (1)
- satisfaction with life (1)
- teeth extraction (1)
- tooth extraction (1)
- treatment benefit (1)
Institute
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (12)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Medizinische Klinik und Poliklinik II (2)
- Comprehensive Cancer Center Mainfranken (1)
- Poliklinik für Zahnärztliche Prothetik (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Since Otto Warburg reported in 1924 that cancer cells address their increased energy requirement through a massive intake of glucose, the cellular energy level has offered a therapeutic anticancer strategy. Methionine restriction (MetR) is one of the most effective approaches for inducing low-energy metabolism (LEM) due to the central position in metabolism of this amino acid. However, no simple in vitro system for the rapid analysis of MetR is currently available, and this study establishes the murine cell line L929 as such a model system. L929 cells react rapidly and efficiently to MetR, and the analysis of more than 150 different metabolites belonging to different classes (amino acids, urea and tricarboxylic acid cycle (TCA) cycles, carbohydrates, etc.) by liquid chromatography/mass spectrometry (LC/MS) defines a metabolic fingerprint and enables the identification of specific metabolites representing normal or MetR conditions. The system facilitates the rapid and efficient testing of potential cancer therapeutic metabolic targets. To date, MS studies of MetR have been performed using organisms and yeast, and the current LC/MS analysis of the intra- and extracellular metabolites in the murine cell line L929 over a period of 5 days thus provides new insights into the effects of MetR at the cellular metabolic level.
Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint inhibitor (ICI) treatment is approved for HNSCC as a first-line treatment in recurrent and metastatic disease. ICI treatment yields a clear survival benefit, but overall response rates are still unsatisfactory. As shown in different cancer models, hepatocyte growth factor/mesenchymal–epithelial transition (HGF/Met) signaling contributes to an immunosuppressive microenvironment. Therefore, we investigated the relationship between HGF and programmed cell death protein 1 (PD-L1) expression in HNSCC cell lines. The preclinical data show a robust PD-L1 induction upon HGF stimulation. Further analysis revealed that the HGF-mediated upregulation of PD-L1 is MAP kinase-dependent. We then hypothesized that serum levels of HGF and soluble programmed cell death protein 1 (sPD-L1) could be potential markers of ICI treatment failure. Thus, we determined serum levels of these proteins in 20 HNSCC patients before ICI treatment and correlated them with treatment outcomes. Importantly, the clinical data showed a positive correlation of both serum proteins (HGF and sPD-L1) in HNSCC patient’s sera. Moreover, the serum concentration of sPD-L1 was significantly higher in ICI non-responsive patients. Our findings indicate a potential role for sPD-L1 as a prognostic marker for ICI treatment in HNSCC.